Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Trastuzumab × Other solid neoplasm × Clear all

Phase

Status

Completed 4 Active not recruiting 3 Unknown 2 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 53 Gastrointestinal 28 Head & Neck 4 Tumor-Agnostic 3 Thoracic 3 Lymphoid 3 Plasma cell 2 Gynecologic 2 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 CNS 1

Conditions

Solid Tumor, Adult 1

Interventions

Injections 41 pembrolizumab 36 Bevacizumab 20 Carboplatin 19 Cyclophosphamide 16 Cisplatin 13 tislelizumab 12 fludarabine 12 Paclitaxel 12 Nivolumab 11 Specimen Handling 10 Cetuximab 10 toripalimab 9 Oxaliplatin 9 Interviews as Topic 9 Fluorouracil 9 atezolizumab 8 Standard of Care 8 Practice Guidelines as Topic 8 Pemetrexed 8 Docetaxel 8 Leucovorin 7 Capecitabine 7 spartalizumab 6 olaparib 6 Educational Status 6 palbociclib 5 lenvatinib 5 Irinotecan 5 Ipilimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092673 2024-05-21

Zotatifin

Effector Therapeutics

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡